The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Open accessAbstract
Background— Whether triple antiplatelet therapy is superior or similar to dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention in the era of drug-eluting stents remains unclear. Methods and Results— A total of 4203 ST-segment elevation myocardial infarction patients who underwent primary percutaneous coronary intervention with drug-eluting stents were analyzed retrospectively in the Korean Acute Myocardial Infarction Registry (KAMIR). They received either dual (aspirin plus clopidogrel; dual group; n=2569) or triple (aspirin plus clopidogrel plus cilostazol; triple group; n=1634) antiplatelet therapy. The triple group received additional cilostazol at least for 1 month. Various major adverse cardiac events at 8 months were compared between these 2 groups. Compared with the dual group, the triple group had a similar incidence of major bleeding events but a significantly lower incidence of in-hospital mortality. Clinical outcomes at 8 months showed that the triple group had significantly lower incidences of cardiac death (adjusted odds ratio, 0.52; 95% confidence interval, 0.32 to 0.84; P =0.007), total death (adjusted odds ratio, 0.60; 95% confidence interval, 0.41 to 0.89; P =0.010), and total major adverse cardiac events (adjusted odds ratio, 0.74; 95% confidence interval, 0.58 to 0.95; P =0.019) than the dual group. Subgroup analysis showed that older (>65 years old), female, and diabetic patients got more benefits from triple antiplatelet therapy than their counterparts who received dual antiplatelet therapy. Conclusions— Triple antiplatelet therapy seems to be superior to dual antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stents. These results may provide the rationale for the use of triple antiplatelet therapy in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Problem With Composite End Points in Cardiovascular Studies
Kip, K. E., Hollabaugh, K., Marroquin, O. C., & Williams, D. O. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.034 · Cited by 348
Cited by
Gogarten, W., Vandermeulen, E., Van Aken, H., Kozek, S., Llau, J. V., & Samama, C. M. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32833f6f6f · Cited by 529
Park, D.-W., Clare, R. M., Schulte, P. J., Pieper, K. S., Shaw, L. K., Califf, R. M., Ohman, E. M., Van de Werf, F., Hirji, S., Harrington, R. A., et al. (2014) · JAMA · doi:10.1001/jama.2014.15095 · Cited by 376
Self-citationHolmes, D. R., Kereiakes, D. J., Garg, S., Serruys, P. W., Dehmer, G. J., Ellis, S. G., Williams, D. O., Kimura, T., & Moliterno, D. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.016 · Cited by 367
De Luca, G., Navarese, E., & Marino, P. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp118 · Cited by 252
Metadata
- Authors
- Chen, K.-Y., Rha, S.-W., Li, Y.-J., Poddar, K. L., Jin, Z., Minami, Y., Wang, L., Kim, E. J., Park, C. G., Seo, H. S., Oh, D. J., Jeong, M. H., Ahn, Y. K., Hong, T. J., Kim, Y. J., Hur, S. H., Seong, I. W., Chae, J. K., Cho, M. C., Bae, J. H., Choi, D. H., Jang, Y. S., Chae, I. H., Kim, C. J., Yoon, J. H., Chung, W. S., Seung, K. B., & Park, S. J.
- Venue
- Circulation
- Published
- 2009-06-30
- Volume
- 119
- Issue
- 25
- Pages
- 3207-3214
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1983980229
- Cited by
- 194
- References
- 1
- FWCI
- 18.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. https://app.cochat.ai/papers/10.1161/circulationaha.108.822791
- The paper
- Chen, K.-Y., Rha, S.-W., Li, Y.-J., Poddar, K. L., Jin, Z., Minami, Y., Wang, L., Kim, E. J., Park, C. G., Seo, H. S., Oh, D. J., Jeong, M. H., Ahn, Y. K., Hong, T. J., Kim, Y. J., Hur, S. H., Seong, I. W., Chae, J. K., Cho, M. C., . . . Park, S. J. (2009). Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circulation. https://doi.org/10.1161/circulationaha.108.822791
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.